1. Home
  2. PRTC vs NOA Comparison

PRTC vs NOA Comparison

Compare PRTC & NOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • NOA
  • Stock Information
  • Founded
  • PRTC 2015
  • NOA 1953
  • Country
  • PRTC United States
  • NOA Canada
  • Employees
  • PRTC N/A
  • NOA N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • NOA Meat/Poultry/Fish
  • Sector
  • PRTC Health Care
  • NOA Consumer Staples
  • Exchange
  • PRTC Nasdaq
  • NOA Nasdaq
  • Market Cap
  • PRTC 432.3M
  • NOA 483.8M
  • IPO Year
  • PRTC N/A
  • NOA 2006
  • Fundamental
  • Price
  • PRTC $18.50
  • NOA $17.18
  • Analyst Decision
  • PRTC Buy
  • NOA
  • Analyst Count
  • PRTC 1
  • NOA 0
  • Target Price
  • PRTC $45.00
  • NOA N/A
  • AVG Volume (30 Days)
  • PRTC 3.2K
  • NOA 75.5K
  • Earning Date
  • PRTC 04-30-2025
  • NOA 05-14-2025
  • Dividend Yield
  • PRTC N/A
  • NOA 1.88%
  • EPS Growth
  • PRTC N/A
  • NOA N/A
  • EPS
  • PRTC 0.21
  • NOA 0.94
  • Revenue
  • PRTC $4,828,000.00
  • NOA $841,544,509.00
  • Revenue This Year
  • PRTC $35.98
  • NOA $11.51
  • Revenue Next Year
  • PRTC $115.38
  • NOA $4.38
  • P/E Ratio
  • PRTC $8.24
  • NOA $18.74
  • Revenue Growth
  • PRTC 44.98
  • NOA 18.89
  • 52 Week Low
  • PRTC $13.30
  • NOA $13.19
  • 52 Week High
  • PRTC $32.98
  • NOA $22.08
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 58.17
  • NOA 60.66
  • Support Level
  • PRTC $17.80
  • NOA $16.24
  • Resistance Level
  • PRTC $19.17
  • NOA $17.56
  • Average True Range (ATR)
  • PRTC 0.48
  • NOA 0.55
  • MACD
  • PRTC 0.13
  • NOA 0.05
  • Stochastic Oscillator
  • PRTC 74.72
  • NOA 76.47

About PRTC PureTech Health plc

PureTech Health PLC, together with its subsidiaries, is a clinical-stage biopharma company developing medicines to modulate the adaptive human system. The company is focused on developing and commercializing differentiated medicines for devastating diseases, including inflammatory, immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological and neuropsychological disorders, among others. Its drug development pipeline consists of Deupirfenidone (LYT-100), for the potential treatment of idiopathic pulmonary fibrosis (IPF), LYT-200, SPT-300, an oral drug for depressive disorder, SPT-320, and others. The company's operating segments include Parent Companies & Other, which derives key revenue, Wholly-Owned Programs, and Controlled Founded Entities.

About NOA North American Construction Group Ltd. (no par)

North American Construction Group Ltd is Canada's heavy civil construction and mining contractor provider. The company has provided services to oil, natural gas, and resource companies. The Company provides a wide range of mining and heavy civil construction services to customer in the resource development and industrial construction sectors within Canada, the United States, and Australia. The Company's reportable segments are Heavy Equipment Canada, Heavy Equipment Australia, and Other. Heavy Equipment Canada and Heavy Equipment Australia include all of aspects of the mining and heavy civil construction services provided within those geographic areas. Other includes mine management contract work in the United States, its external maintenance and rebuild programs.

Share on Social Networks: